Core Viewpoint - *ST Changyao's subsidiary, Hebei Yiheng Technology Co., Ltd., has recently ceased production due to the competitive environment in the photovoltaic industry and the subsidiary's financial difficulties, including ongoing losses. The decision aims to prevent further losses, reduce operating costs, and protect shareholder interests. The company will evaluate market conditions to determine if production will resume in the future. The suspension of operations will not adversely affect the normal production and business activities of the company's pharmaceutical sector [1]. Group 1 - Hebei Yiheng Technology has decided to stop production to mitigate losses and lower operational costs [1] - The photovoltaic industry is currently facing a competitive environment, contributing to the decision to cease operations [1] - The suspension of production will not impact the pharmaceutical business of *ST Changyao [1]